Pharmaceutical Discovery Services

SRI's pharmaceutical discovery teams brings more than 40 years of interdisciplinary scientific expertise to our clients. Our goal is to assist government and private clients at all stages of the drug discovery cycle as they seek to rapidly identify and optimize new drug leads and move them into preclinical development.

Scope of Services

We provide discovery contract research and services to clients worldwide, delivering the experience and resources needed to bridge the gap from drug discovery to development. Our interdisciplinary teams combine expertise in molecular biology, biochemistry, immunology, medicinal chemistry, synthetic and process chemistry, pharmacology, computer-aided drug design, molecular modeling, and assay design and implementation to address client needs. From basic biological research and target identification to lead discovery and optimization to in vitro screening and in vivo efficacy testing, we work with clients to help them rapidly iterate through the discovery process as they pursue promising leads.

Our capabilities in both in vitro and in vivo testing provide a seamless transition effectively complementing a client's in-house capabilities. SRI's customized drug screening capabilities can provide valuable insights into the potential of new compounds. We design each study to optimize the client's time and resources, and incorporate a broad range of capabilities to ensure the best efficacy evaluation of the client's compounds. Post-discovery, we are available to work with clients to move from the lab into clinical formulations, testing, and eventually to market.

We offer

• Basic research
• Medicinal chemistry and custom synthesis
• In Vitro efficacy/ADME screening
• In Vivo efficacy evaluation
• Comprehensive drug development services

Contact Us

     Last Updated Jul 17, 2008